Aranscia, a diagnostics software and testing solutions provider, has acquired specific assets of YouScript, a leading personalized medication management platform, from Invitae Corporation in an all-cash deal. YouScript offers real-time medication risk and pharmacogenomics insights, aiding healthcare providers in personalized medication programs. It will integrate into Aranscia’s portfolio alongside 2bPrecise (EMR-integrated PGx solutions), SinguLab (diagnostics services network), and AccessDx Laboratory (specializing in PGx operations).
Aranscia, a global provider of diagnostics software, services, and testing solutions, has acquired select assets of the YouScript personalized medication management platform from Invitae Corporation in an all-cash transaction.
YouScript is a widely recognized leader in providing actionable, real-time medication risk and pharmacogenomics (PGx) insights. It enables healthcare providers and organizations to build, deliver, and scale comprehensive personalized medication management programs.
YouScript will join the Aranscia portfolio of companies, which includes 2bPrecise (lab-agnostic, EMR-integrated solutions for PGx, population health insights, and precision oncology workflows), SinguLab (a national network of diagnostics services support), and AccessDx Laboratory (a CLIA-certified, CAP accredited, and NYCQ molecular diagnostic laboratory with specialist expertise in PGx operations).
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
Source: Hitconsultant